Home » HemCon Announces Development Agreement
HemCon Announces Development Agreement
HemCon Medical Technologies Inc. announced a development agreement with a company in England to develop a sterile, single-use antibody capture device for the removal of isoagglutinin antibodies.
Portland Business Journal
Portland Business Journal
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May